uniQure (QURE) Operating Income (2016 - 2026)
uniQure's (QURE) quarterly Operating Income came in at -$45.7 million in Q1 2026, down 16.24% year-on-year from -$54.6 million in Q1 2025, and up 10.56% quarter-over-quarter from -$51.1 million in Q4 2025.
uniQure (QURE) Operating Income (2016 - 2026) Analysis & Trends
uniQure's Operating Income history runs 11 years deep, the most recent figure standing at -$45.7 million for Q1 2026.
- On a quarterly basis, Operating Income fell 16.24% year-over-year to -$45.7 million in Q1 2026; TTM through Mar 2026 was -$191.7 million, a 13.19% decrease from a year earlier, with the FY2025 full-year figure at -$185.3 million, down 0.57% from the prior year.
- Operating Income advanced to -$45.7 million in Q1 2026 per QURE's latest filing, from -$51.1 million in the prior quarter.
- Across five years, Operating Income topped out at $26.5 million in Q4 2022 and bottomed at -$81.9 million in Q3 2023.
- The 5-year median for Operating Income is -$51.1 million (2025), against an average of -$49.5 million.
- Across the five-year window, Operating Income soared 1181.48% in 2022 and plunged 333.0% in 2023, its largest moves.
- Year by year, Operating Income stood at $26.5 million in 2022, then plunged by 333.0% to -$61.7 million in 2023, then increased by 25.78% to -$45.8 million in 2024, then retreated by 11.54% to -$51.1 million in 2025, then rose by 10.56% to -$45.7 million in 2026.
- Per Business Quant, the three latest QURE Operating Income figures stand at -$45.7 million (Q1 2026), -$51.1 million (Q4 2025), and -$51.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | -45.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.72 Mn |
| Dec 31, 2025 | -51.12 Mn |
| Sep 30, 2025 | -51.04 Mn |
| Jun 30, 2025 | -43.87 Mn |
| Mar 31, 2025 | -39.33 Mn |
| Dec 31, 2024 | -45.83 Mn |
| Sep 30, 2024 | -40.23 Mn |
| Jun 30, 2024 | -44.01 Mn |
| Mar 31, 2024 | -54.23 Mn |
| Dec 31, 2023 | -61.75 Mn |
| Sep 30, 2023 | -81.88 Mn |
| Jun 30, 2023 | -65.07 Mn |
| Mar 31, 2023 | -74.17 Mn |
| Dec 31, 2022 | 26.50 Mn |
| Sep 30, 2022 | -59.52 Mn |
| Jun 30, 2022 | -56.06 Mn |
| Mar 31, 2022 | -54.08 Mn |
| Dec 31, 2021 | 2.07 Mn |
| Sep 30, 2021 | -45.00 Mn |
| Jun 30, 2021 | 398.01 Mn |